HOME >> BIOLOGY >> NEWS
Mutant Gene Not Sole Explanation For Hiv Non-Progression

e a cellular receptor called CCR5, in addition to the CD4 molecule, to enter certain of its target cells. HIV-infected people with a specific mutation in one of their two copies of the gene for this receptor generally have a slower disease course than people with two normal copies of the gene. People with two mutant copies of the CCR5 gene appear -- in most cases -- to be completely protected from HIV infection.

Several epidemiological studies have shown that individuals with one mutant copy of the CCR5 gene are disproportionately represented among long-term nonprogressors. The LIR defines long-term nonprogressors as people who have been HIV-infected for more than seven years, have stable CD4+ T cell counts above 600 per cubic millimeter (mm3) of blood, have no history of HIV-related symptoms, and who have not taken antiretroviral drugs.

Drs. Cohen, Fauci and their team began recruiting long-term nonprogressors five years ago to determine the specific factors that protect these people from HIV disease progression. Soon after the discovery of the role of CCR5 in HIV disease and the association of the mutant CCR5 gene with slower disease progression, the LIR team found that people with one copy of the mutant gene (and one copy of the normal gene) were over-represented in their cohort of long-term nonprogressors.

With that
'"/>

Contact: Greg Folkers
gfolkers@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
15-Sep-1997


Page: 1 2 3 4 5

Related biology news :

1. Mutant mice lead to memory insights
2. Mutant biological machine makes proteins but cant let go
3. Mutant gene linked to obsessive compulsive disorder
4. Mutant gene found to cause early ovarian failure in mice
5. Mutants from a lowly weed may solve maladies
6. Mutant proteins may be key to defeat chemical warfare
7. Protein Misfolding, Not Mutant Gene, Key To Lethal Sleep Disorder
8. Mechanism Discovered For Determining Early Vertebrate Body Plan: New Zebrafish Mutants Afford Deeper Look Into Embryonic Patterning
9. MITs Mini Respirator Breathes Life Into Mutant Mice
10. Induced Mutant Mouse Models Of Lipoprotein Disorders And Atherosclerosis
11. Single Mechanism Seen To Underlie Group Of Neurodegenerative Diseases: Mutant Proteins Form Insoluble Masses In The Nuclei Of Neurons

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mutant Gene Not Sole Explanation For Hiv Non Progression

(Date:5/23/2013)... mechanism by which estrogen suppresses lipid synthesis in the ... approach toward treating certain liver diseases. , With ... are changing long-held views in the field. Study results ... Science Signaling . , "The dogma in the ... only receptors located in the nucleus respond to steroid ...
(Date:5/23/2013)... new report from the Institute of Medicine says schools ... least 60 minutes of vigorous or moderate intensity activity ... of American youth meet current evidence-based guidelines of at ... activity daily, according to the report, which was released ... nearly half of their waking hours, the committee recommends ...
(Date:5/23/2013)... in Neuron , the team reveal the interplay ... work funded by the Wellcome Trust and BBSRC. ... stimuli we improve our perceptual abilities. While these changes ... can also affect the fidelity of that response. ... Neuroscience explains: "When you communicate with others, you can ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide students with daily physical activity, IOM recommends 2
(Date:5/23/2013)... San Francisco, CA (PRWEB) May 23, 2013 ... do-it-yourselfers who encourage all types of inventions. They focus ... we’re now noticing this community gravitate toward bringing their ... community, the DIY Biology Movement, works on making projects ... sequencing the DNA of plants to make them glow ...
(Date:5/23/2013)... Virobay, Inc. today announced that their development ... important milestone, as Virobay has now initiated a Phase ... S inhibitor.   The first Phase 1 ... designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics ... "The initiation of this Phase 1 trial with ...
(Date:5/23/2013)... , May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... developing DCVax ® personalized immune therapies for solid ... exhibit at this year,s American Society Of Clinical Oncology ... highlight its leadership role in immune therapy.  ... annual meeting is the pre-eminent conference focused on clinical ...
(Date:5/23/2013)... Toronto, Canada (PRWEB) May 23, 2013 ... subjects, it is critical to adhere to principles ... protection (HSP). , Esteemed speaker Dr. Jeremy Lim, ... the audience: , ,     Understand the ... Clinical Practice (GCP) and additional regulations for the ...
Breaking Biology Technology:Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2
Cached News: